Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CureBio appears to be a South Korea-based life science products and laboratory supply business rather than a drug-development biotech. Publicly available sources indicate the company has operated as a distributor of research reagents, lab equipment, consumables, and internally branded products, including buffers, pipette tips, prep kits, and competent cells. The company has described itself as a domestic distributor for major life science suppliers such as Thermo Fisher and Merck, and as an agent for additional foreign brands. Recent website content suggests an operating-name transition toward K-Bio Company, while CureBio continues to function as a brand and email/domain identity. There is no reliable evidence from accessible primary sources that this specific CureBio entity has a therapeutic drug pipeline or clinical-stage assets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CureBio.